Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
Long Covid & Fatiguing Illness Recovery Program
Research Update Featuring: Avindra Nath, MD (Clinical Director of National Institute of Neurological Disorders and Stroke – NIH; Chief of the Section of Infections of the Nervous System – NIH; […]
Leveraging EHR/Real World Data to Understand PASC
Join the National Health Institutes (NIH) RECOVER Research Review (R3) Seminar Series, “Leveraging EHR/Real World Data to Understand PASC,” by registering here: http://ow.ly/sZep50Jg45C. The goal of the R3 Seminar Series is to […]
Solve M.E. CEO Oved Amitay and Dr. Leonard Jason Write Letter to the Editor, Nature
DePaul Univeristy Professor of Psychology Leonard Jason, PhD and Solve M.E. President and CEO Oved Amitay recently co-authored a response to a Nature article linking Epstein-Barr virus (EBV) and multiple […]
Long COVID & Fatiguing Illness Recovery Program ECHO
History of ME/CFS Lucinda Bateman, MD Medical Director, Provider, & Research expert in the diagnosis and treatment of ME/CFS. Founder and Chief Medical Officer of the Bateman Horne Center of […]
